to the post # 4 jackarse....
CV rep here....launched Diovan into what it is today - a multi-billion dollar drug....Yes we bought some business, but everybody did at the time....it was a level playing field.
Novartis is hanging by a thread with Patch, they want to make it into a big deal that the higher dose will be approved; however, the majority of docs dont even titrate (means to increase the dose in case you didnt know) from 4.6 up to the next dose (9.5).
1-2 years ago, Novartis never gave any money towards Patch when I was selling it (yes I got put on the product for a year , as well as Reclast). They knew it was a mediocre option. Plus the red markings, itching happens a lot more than people think!
Reclast - too bad the paperwork is a nightmare. If I were a doctor, I wouldnt be bothered with this option cause getting it approved, getting an appointment set up to be infused, etc...My patient could be on a pill for over 15-20 days before all that crap is done!
And dont give me.."oh, but its once a year, and oral meds you have to wait a 1/2 hour to eat or drink, and you cant take it with orange juice, you need to sit upright...." Really? explain the billions that have been made with Boniva, Fosamax, etc....